Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52,265,866
-
Total 13F shares
-
24,268,026
-
Share change
-
+2,172,781
-
Total reported value
-
$144,878,758
-
Price per share
-
$5.97
-
Number of holders
-
99
-
Value change
-
+$14,267,162
-
Number of buys
-
55
-
Number of sells
-
39
Institutional Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q2 2016
As of 30 Jun 2016,
ENZO BIOCHEM INC - Common Stock (ENZB) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,268,026 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, First Light Asset Management, LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Fund Advisors, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and GILDER GAGNON HOWE & CO LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.